PHAGE BIOTECHNOLOGY CORP has a total of 20 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology and pharmaceuticals are RENTSCHLER BIOTECH GMBH, SENTINELLA PHARMACEUTICALS INC and CYNATA THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | Canada | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Fermentation | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Kordyum Vitaliy A | 16 |
#2 | Vozianov Oleksandr F | 15 |
#3 | Slavchenko Iryna Yu | 12 |
#4 | Chernykh Svitlana I | 12 |
#5 | Stegmann Thomas J | 5 |
#6 | Qin Shiliang | 4 |
#7 | Li Huaina | 4 |
#8 | Chernykh Svetlana I | 4 |
#9 | Slavchenko Irina Y | 4 |
#10 | Jacobs John W | 4 |
Publication | Filing date | Title |
---|---|---|
KR20080041661A | Human growth hormone conjugated with biocompatible polymer | |
WO0214471A2 | A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis | |
WO0214468A2 | Phage-dependent superproduction of biologically active protein and peptides | |
US6268178B1 | Phage-dependent super-production of biologically active protein and peptides |